NEPHROLOGY*
*See
also the American
Society for Pediatric Nephrology Program
Saturday, May 4, 2002
1:00pm – 3:00pm
ASPN Symposium
4140A
Vasculitis and Renal Disease in Children
Chairs: Sharon P. Andreoli,
Indiana University, Indianapolis, IN, and Allison Eddy,
University of Washington, Seattle, WA
Diagnosis of Vasculitic Renal Disease in Children
Thomas J.A. Lehman, Cornell Medical Center, New
York, NY
ANCA Associated Renal Disease in Children
Debbie Gipson, University of North Carolina, Chapel
Hill, NC
Transition of Acute Glomerulonephritis to End Stage
Renal Disease
Allison A. Eddy, University of Washington, Seattle,
WA
Management and Therapy of Lupus Nephritis
James E. Balow, NIDDK, National Institutes of
Health, Bethesda, MD
3:15pm – 5:15pm
Topic Symposium
4200
Cloning and Embryonic Stem Cells
Chair: Judith Hall,
University of British Columbia, Vancouver, Canada
There is enormous public interest in cloning and
embryonic stem cells. This symposium will update the
pediatric community on recent developments and raises a
variety of policy and ethical issues.
Overview
Judith G. Hall, University of British Columbia,
Vancouver, Canada
Imprinting and Reprogramming
Arthur L. Beaudet, Baylor College of Medicine,
Houston, TX
Cloning
Brigid Hogan, Vanderbilt University Medical Center
and the Howard Hughes Medical Institute, Nashville, TN
Embryonic Stem Cells
Janet Rossant, Samuel Lunenfeld Research Institute,
Mount Sinai Hospital ON, Canada
3:15pm – 5:15pm
Platform Session
4257
Nephrology I
Chairs: Robert H. K. Mak
and Teri Jo Mauch
5:15pm – 7:15pm
Poster Session I (Author Attended)
and Opening Reception
– Nephrology
Sunday, May 5, 2002
10:15am – 11:45am
Award
5190
APS Presidential Plenary, Howland Award & (11:15 AM)
St. Geme Award
APS Presidential Address
Judith G. Hall, University of
British Columbia, Vancouver, Canada
APS Howland Award Lecture
Howard A. Pearson
Joseph W. St. Geme, Jr. Leadership Award
Walter W. Tunnessen
Sunday, May 5, 2002
11:45am – 1:45pm
Poster Session II (Author Attended)
– Nephrology
1:45pm – 2:30pm
State of the Art Plenary
5590
Children as Victims of Bioterrorism: Protecting the
Fragile Host
Chairs: Phyllis Dennery,
Stanford University School of Medicine, Palo Alto, CA
and Tina Lee Cheng, Johns Hopkins University School of
Medicine, Baltimore, MD
With the recent world events
and new threats of biowarfare, what should pediatricians
know? Due to their size and physiology, children are at
higher risk of injury from bioterrorism. This session
will address the biology, clinical manifestations, and
possible preventive strategies for likely biowarfare
agents. The unique vulnerability of the child will be
addressed.
Overview
Phyllis A. Dennery, Stanford University School of
Medicine, Palo Alto, CA
Children as Victims of Bioterrorism: Protecting the
Fragile Host
Ralph D. Feigin, Baylor College of Medicine,
Houston, TX
Discussion
2:00pm
– 4:00pm
Topic Symposium
5700
Cancer, Blood and the Kidney: Common Themes
Chair: Ellis D. Avner,
President-Elect, American Society of Pediatric
Nephrology and George R. Buchanan, President, American
Society of Pediatric Hematology/Oncology
Many children with cancer,
hematological disorders, or kidney disease have complex,
multisystem problems. Advances in cell and molecular
biology provide insights into the interrelationships of
cancer, blood, and the kidney and have led to new
diagnostic and therapeutic approaches for the clinician.
Such approaches are reviewed in this symposium, which
focuses specifically on the nephrological complications
of sickle cell anemia and bone marrow transplantation,
hematological complications of nephrotic syndrome, and
the molecular pathophysiology of WT-1-associated
disorders.
Sickle Cell Nephropathy: Pathophysiology and Therapy
Jon Scheinman, University of Kansas Medical Center,
Kansas City, KS
Thromboembolic Complications of the Nephrotic
Syndrome
M. Patricia Massicotte, University of Toronto, The
Hospital for Sick Children, Toronto, Canada
Renal Complications of Bone Marrow Transplantation
Ruth McDonald, University of Washington/Children's
Hospital & Regional Medical Center, Seattle, WA
Molecular Pathophysiology of Wilm's Tumor and
Denys-Drash/Frasier Syndromes
Max J. Coppes, Alberta Children's Hospital, Alberta,
Canada
Sponsored jointly with the American Society of
Pediatric Hematology/Oncology and the American Society
of Pediatric Nephrology
2:00pm – 4:00pm
State of the Art Plenary
5701
Children as Research Subjects: Ethical and Regulatory
Issues
Chair: Myron Genel, Yale
University School of Medicine, New Haven, CT
A number of highly publicized
adverse events, including the death of two volunteers
participating in non-therapeutic research, and the
federal shutdown of research at many well-recognized
academic institutions because of inadequate compliance
with regulatory requirements have intensified scrutiny
of the protection afforded to human subjects
participating in research, including children.
Furthermore a Maryland court has recently decreed that
children cannot participate in research without the
potential for direct benefit. As a consequence there has
been increasing media attention and Congressional
concern regarding the adequacy of institutional
oversight and investigator attentiveness to established
standards and regulations. In addition, new regulations
issued under the Health Insurance Portability and
Accountability Act of l996(HIPAA) threaten the capacity
to conduct health services and outcomes research. These
issues will be addressed in the 9th annual Public Policy
Plenary Symposium in an interactive format intended to
stimulate dialogue among the members of the panel and
with the audience.
Overview
Myron Genel, Yale University School of Medicine, New
Haven, CT
Overseeing Research in Children: New Concerns and New
Regulations
Alan R. Fleischman, The New York Academy of
Medicine, New York, NY
International Health Research: Where Bioethics,
Politics and Economics Converge
Eric M. Meslin, Indiana University Center for
Bioethics, Indianapolis, IN
Compliance: What You and Your Institution Need to
Know (and Do)
Pearl O'Rourke, Partners HealthCare System, Inc.,
Boston, MA
HIPAA, Privacy & Confidentiality and Research In
Children?
Brian Kamoie, The George Washington University,
Washington, DC
Discussion
Sponsored jointly with the Public Policy Council
of the APS, AMSPDC, SPR and the Public Policy Committee
of the APA
Partially supported by an educational grant from
Columbus Children's Hospital
4:15pm – 6:15pm
Platform Session
5909
Nephrology II
Chairs: Deborah P. Jones
and Pascale H. Lane
Monday, May 6, 2002
10:00am – 12:00pm
ASPN Symposium
6120A
Molecular Basis of Renal Development and Disease
Chairs: Ellis D. Avner,
Rainbow Babies & Children's Hospital, Cleveland, OH,
and Paul R. Goodyer, McGill University, Montreal Canada
Renal Development: A Molecular Overview
Christopher R. Burrow, Mt. Sinai School of Medicine,
New York, NY
Pax 2 in Renal Maldevelopment
Paul R. Goodyer, McGill University, Montreal, Canada
Developmental Interactions of the Renin-Angiotensin
System with Cyclooxygenase-2
Victoria F. Norwood, University of Virginia,
Charlottesville, VA
Polycystin: Kidney Development and PKD
Patricia D. Wilson, Mt. Sinai School of Medicine,
New York, NY
1:00pm – 3:00pm
ASPN Symposium
6420A
ESRD — Long Term Issues
Chairs: Frederick J. Kaskel,
Albert Einstein College of Medicine, New York, NY, and
Craig Wong, Children's Hospital of New Mexico,
Albuquerque, NM
Cardiovascular Risk Factors in ESRD
Rulan Parekh, Johns Hopkins University, Baltimore,
MD
Modifications of Cardiovascular Risk Factors
Ronald J. Portman, University of Texas, Houston, TX
Update on Bone Disease in ESRD
Mary Beth Leonard, The Children's Hospital of
Philadelphia, Philadelphia, PA
Advances In Dialytic Therapies
Stuart Goldstein, Texas Children's Hospital,
Houston, TX
2:45pm – 4:45pm
Platform Session
6557
Mechanisms of Tissue Injury: Apoptosis
Chairs: Sandra E. Juul and
Seetha Shankaran
Tuesday, May 7, 2002
1:45pm – 3:45pm
Hot Topic
7702
Disaster Preparedness: Beyond 9/11
Chairs: Tina L. Cheng,
Johns Hopkins University School of Medicine, Baltimore,
MD; Danielle Laraque, Mount Sinai School of Medicine,
New York, NY; and Benard Dreyer, New York, NY
The impact of 9/11 and the
public health aftermath have affected us personally and
professionally. This session will address what the child
health professional needs to know regarding disaster
planning and preparedness. Speakers will review and
provide updates on national and regional systems for
emergency management and how those systems interact with
local public health agencies, the pediatrician's role in
the community's preparedness including what the school
system, the pediatric office and the patient should be
doing to prepare and respond, recognition and management
of chemical and biologic agents of terrorism, and the
psychological reactions to disaster and stress.
Disaster Planning and Preparedness for Child Health
Professionals
George L. Foltin, New York University School of
Medicine and Bellevue Hospital Center, New York, NY
Biologic Agents of Terrorism
Anne Fine, New York City Department of Health, New
York, NY
Chemical Agents of Terrorism
Fred Henretig, University of Pennsylvania School of
Medicine and Children's Hospital of Philadelphia,
Philadelphia, PA
Helping Children Cope with Terrorism and Disasters
David J. Schonfeld, Yale University School of
Medicine, New Haven, CT
Discussion
|
